Cardiovascular action of insulin-like growth factor-1 is not mediated by calcitonin gene-related peptide neurons

Endocrine

Volumn 19, Issue 2, 2002, Pages 163-167

  McRae, Crystal R ^a   Rao, Sumangala P ^a   Dunbar, Joseph C ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcitonin gene related peptide; Capsaicin; Diabetic; Insulin like growth factor 1; Mean arterial pressure

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; SOMATOMEDIN C;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR EFFECT; CELL SUBPOPULATION; CONDUCTANCE; CONTROLLED STUDY; HEART RATE; ILIAC ARTERY; MEAN ARTERIAL PRESSURE; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; SUPERIOR MESENTERIC ARTERY; VASODILATATION;

EID: 0036876106     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:19:2:163     Document Type: Article

References (27)

1. Zapf, J., Schmid, C., and Froesch, E. R. (1984). Clin. Endocrinol. Metab. 13, 3-30.
2. Adams, T. E., Epa, V. C., Garrett, T. P., and Ward, C. W. (2000). Cell Mol. Life Sci. 57, 1050-1093.
3. Pete, G., Hu, Y., Walsh, M., Sowers, J., and Dunbar, J. C. (1996). Proc. Exp. Biol. Med. 213, 187-192.
4. Pete, G. and Dunbar, J. C. (1998). Clin. Exp. Hypertens. 20, 67-83.
5. Walsh, M. F., Barazi, M., Pete, G., Muniyappa, R., Dunbar, J. C., and Sowers, J. R. (1996). Endocrinology 137, 1798-1803.
6. Gillespie, C. M., Merkel, A. L., and Martin, A. A. (1997). J. Endocrinol. 155, 351-358.
7. Muniyappa, R., Walsh, M. F., and Rangi, J. S., et al. (1997). Life Sci. 61, 925-931.
8. Duanmu, Z., Lapanowski, K., and Dunbar, J. C. (1997). Proc. Exp. Biol. Med. 216, 93-97.
9. Sowers, J. R. (1997). Hypertension 29, 691-699.
10. Hauck, C. M. and Dunbar, J. C. (1999). Acta Diabetol. 36, 53-60.
11. Dunbar, J. C., O'Leary, D. S., Wang, G., and Wright-Richey, J. (1996). Acta Diabetol. 33, 263-268.
12. Salem, N. and Dunbar, J. C. (2002). Diabetes Metab. Res. Rev. 18, 238-244.
13. Kawasaki, H. (2002). Jpn. J. Pharmacol. 88, 37-43.
14. Edvinsson, L., Juul, R., and Jansen, I. (1994). Acta Neurol. Scand. 90, 324-330.
15. Preibisz, J. J. (1993). Am. J. Hypertens. 6, 434-450.
16. White, C. B., Roberts, A. M., and Joshua, I. G. (1993). Am. J. Physiol. 265, H1411-H1415.
17. Gennari, C. and Fischer, J. A. (1985). Calcif. Tissue Int. 37, 581-584.
18. Nakamura, T., Naruse, S., Ozaki, T., and Kumada, K. (1996). Regul. Pept. 65, 211-217.
19. Shen, Y. T., Pittman, T. J., Buic, P. S., et al. (2001). J. Pharmacol. Exp. Ther. 298, 551-558.
20. Gangula, P. R., Zhao, H., Supowit, S. C., et al. (2000). Hypertension 35, 470-475.
21. Fisher, L. A., Kikkawa, D. O., Rivier, J. E., et al. (1983). Nature 305, 534-536.
22. Siren, A. L. and Feuerstein, G. (1988). J. Pharmacol. Exp. Ther. 247, 69-78.
23. Takenaga, M. and Kawasaki, H. (1999). Eur. J. Pharmacol. 367, 239-245.
24. Mantelli, L., Amerini, S., Filippi, S., and Ledda, F. (1992). Neuropeptides 23, 193-198.
25. Gray, D. W. and Marshall, I. (1992). Br. J. Pharmacol. 107, 691-696.
26. Sternini, C., Reeve, J. R. Jr., and Brencha, N. (1987). Gastroenterology 93, 852-862.
27. Wimalawansa, S. J. (1993). Peptides 14, 247-252.